Journal article
Higher or Lower Hemoglobin Transfusion Thresholds for Preterm Infants
The New England journal of medicine, Vol.383(27), pp.2639-2651
12/31/2020
DOI: 10.1056/NEJMoa2020248
PMCID: PMC8487591
PMID: 33382931
Abstract
Limited data suggest that higher hemoglobin thresholds for red-cell transfusions may reduce the risk of cognitive delay among extremely-low-birth-weight infants with anemia.
We performed an open, multicenter trial in which infants with a birth weight of 1000 g or less and a gestational age between 22 weeks 0 days and 28 weeks 6 days were randomly assigned within 48 hours after delivery to receive red-cell transfusions at higher or lower hemoglobin thresholds until 36 weeks of postmenstrual age or discharge, whichever occurred first. The primary outcome was a composite of death or neurodevelopmental impairment (cognitive delay, cerebral palsy, or hearing or vision loss) at 22 to 26 months of age, corrected for prematurity.
A total of 1824 infants (mean birth weight, 756 g; mean gestational age, 25.9 weeks) underwent randomization. There was a between-group difference of 1.9 g per deciliter (19 g per liter) in the pretransfusion mean hemoglobin levels throughout the treatment period. Primary outcome data were available for 1692 infants (92.8%). Of 845 infants in the higher-threshold group, 423 (50.1%) died or survived with neurodevelopmental impairment, as compared with 422 of 847 infants (49.8%) in the lower-threshold group (relative risk adjusted for birth-weight stratum and center, 1.00; 95% confidence interval [CI], 0.92 to 1.10; P = 0.93). At 2 years, the higher- and lower-threshold groups had similar incidences of death (16.2% and 15.0%, respectively) and neurodevelopmental impairment (39.6% and 40.3%, respectively). At discharge from the hospital, the incidences of survival without severe complications were 28.5% and 30.9%, respectively. Serious adverse events occurred in 22.7% and 21.7%, respectively.
In extremely-low-birth-weight infants, a higher hemoglobin threshold for red-cell transfusion did not improve survival without neurodevelopmental impairment at 22 to 26 months of age, corrected for prematurity. (Funded by the National Heart, Lung, and Blood Institute and others; TOP ClinicalTrials.gov number, NCT01702805.).
Details
- Title: Subtitle
- Higher or Lower Hemoglobin Transfusion Thresholds for Preterm Infants
- Creators
- Haresh KirpalaniEdward F BellSusan R HintzSylvia TanBarbara SchmidtAasma S ChaudharyKaren J JohnsonMargaret M CrawfordJamie E NewmanBetty R VohrWaldemar A CarloCarl T D'AngioKathleen A KennedyRobin K OhlsBrenda B PoindexterKurt SchiblerRobin K WhyteJohn A WidnessJohn A F ZupancicMyra H WyckoffWilliam E TruogMichele C WalshValerie Y ChockAbbot R LaptookGregory M SokolBradley A YoderRavi M PatelC Michael CottenMelissa F Carmen - University of RochesterUday DevaskarSanjay ChawlaRuth SeabrookRosemary D HigginsAbhik DasEunice Kennedy Shriver NICHD Neonatal Research Network
- Resource Type
- Journal article
- Publication Details
- The New England journal of medicine, Vol.383(27), pp.2639-2651
- DOI
- 10.1056/NEJMoa2020248
- PMID
- 33382931
- PMCID
- PMC8487591
- NLM abbreviation
- N Engl J Med
- ISSN
- 0028-4793
- eISSN
- 1533-4406
- Grant note
- U01 HL112776 / NHLBI NIH HHS UG1 HD068244 / NICHD NIH HHS UG1 HD053109 / NICHD NIH HHS UG1 HD027904 / NICHD NIH HHS U24 HD095254 / NICHD NIH HHS U01 HL112748 / NHLBI NIH HHS KL2 TR003168 / NCATS NIH HHS U10 HD027904 / NICHD NIH HHS
- Language
- English
- Date published
- 12/31/2020
- Academic Unit
- Stead Family Department of Pediatrics; Neonatology
- Record Identifier
- 9984353881002771
Metrics
29 Record Views